Faes Farma Competitors and Similar CompaniesClear all
Faes Farma's competitors and similar companies include STADA and EyePoint Pharmaceuticals.
 Faes Farma Faes Farma is a pharmaceutical company that develops, produces and commercializes pharmaceutical products and raw materials. |  EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. | ||
Founding Date | Founding Date 1933 | Founding Date 1895 | Founding Date 1987 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Leioa, ES HQ Madrid, ES Atlanta, US | Locations Bad Vilbel, DE HQ Beijing, CN Hangzhou Shi, CN Shanghai, CN Bad Vilbel, DE Budapest, HU Vilnius, LT see more | Locations Watertown, US HQ |
Employees | Employees 1,775 | Employees 12,33911% increase | Employees 8453% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 6 b | Valuation ($) 617.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) €493.6m (FY, 2024) | Revenue (est.) €3b (FY, 2020) | Revenue (est.) $31.4m (FY, 2025) |
Cost of goods | Cost of goods €167.1m (FY, 2024) | Cost of goods €1.3b (FY, 2020) | Cost of goods N/A |
Gross profit | Gross profit €342.9m (FY, 2024) | Gross profit €1.7b (FY, 2020) | Gross profit N/A |
Net income | Net income €111.1m (FY, 2024) | Net income €181.9m (FY, 2020) | Net income ($232m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
STADA
HQ
Bad Vilbel, DE
Employees
12,339↑ 11% increase
STADA Arzneimittel is a company engaged in the healthcare and pharmaceuticals business.
View companyEyePoint Pharmaceuticals
HQ
Watertown, US
Employees
84
EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.
View company